[[VIEW_THIS]]. USPTO Alert. US Patent and Trademark Office. September 20: Join the USPTO, ITA, and NIST for a public listening session on standards and intellectual property. Event at USPTO headquarters seeks stakeholder feedback on newly published …
See Original Article

While 1st-line treatment with immune checkpoint inhibitors with or without chemotherapy has improved outcomes for patients with NSCLC without actionable genomic alterations, like EGFR or ALK, most patients eventually experience disease progression.3- …
See Original Article